Literature DB >> 12884427

Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up.

A K Mostert1, P F Dijkstra, B R H Jansen, J R van Horn, B de Graaf, P Heutink, D Lindhout.   

Abstract

In this study, we followed-up the family with bilateral hereditary micro-epiphyseal dysplasia (BHMED) originally described by Elsbach [1959: J Bone Joint Surg [Br] 41-B:514-523]. Clinical re-examination of all available family members resulted in further delineation of the clinical and radiological phenotype, which is distinct from common multiple epiphyseal dysplasia (MED). Linkage analysis excluded EDM1, EDM2, and EDM3 as candidate genes. Linkage and mutation analysis of matrilin-3 (MATN-3) revealed a new pathogenic mutation confirming that BHMED is indeed a distinct disease entity among MED and MED-like disorders. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884427     DOI: 10.1002/ajmg.a.20034

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand.

Authors:  J L Min; I Meulenbelt; N Riyazi; M Kloppenburg; J J Houwing-Duistermaat; A B Seymour; C M van Duijn; P E Slagboom
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

Review 2.  MED, COMP, multilayered and NEIN: an overview of multiple epiphyseal dysplasia.

Authors:  Ralph S Lachman; Deborah Krakow; Daniel H Cohn; David L Rimoin
Journal:  Pediatr Radiol       Date:  2004-10-21

3.  Proteolytic processing causes extensive heterogeneity of tissue matrilin forms.

Authors:  Harald W A Ehlen; Gerhard Sengle; Andreas R Klatt; Anja Talke; Stefan Müller; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

4.  Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis.

Authors:  Louise van der Weyden; Lei Wei; Junming Luo; Xu Yang; David E Birk; David J Adams; Allan Bradley; Qian Chen
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  Matrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist.

Authors:  Xu Yang; Samir K Trehan; Yingjie Guan; Changqi Sun; Douglas C Moore; Chathuraka T Jayasuriya; Qian Chen
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

7.  Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3.

Authors:  Sally L Cotterill; Gail C Jackson; Matthew P Leighton; Raimund Wagener; Outi Mäkitie; William G Cole; Michael D Briggs
Journal:  Hum Mutat       Date:  2005-12       Impact factor: 4.878

8.  An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Authors:  Karen L Posey; Alka C Veerisetty; Pieman Liu; Huiqiu R Wang; Brian J Poindexter; Roger Bick; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

9.  Matrilin-3 is dispensable for mouse skeletal growth and development.

Authors:  Yaping Ko; Birgit Kobbe; Claudia Nicolae; Nicolai Miosge; Mats Paulsson; Raimund Wagener; Attila Aszódi
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 10.  The unfolded protein response and its relevance to connective tissue diseases.

Authors:  Raymond P Boot-Handford; Michael D Briggs
Journal:  Cell Tissue Res       Date:  2009-10-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.